48
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data

, , , , , , , , , , & show all
Pages 2185-2192 | Published online: 13 Oct 2015

References

  • Committee GEGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated 2015 Available from: http://www.goldcopd.orgAccessed September 11, 2015
  • WiseRAThe value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progressionAm J Med200611941116996894
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • TashkinDPCelliBRDecramerMLystigTLiuDKestenSEfficacy of tiotropium in COPD patients with FEV1 ≥60% participating in the UPLIFT® trialCOPD2012928929622432932
  • DecramerMCelliBKestenSLystigTMehraSTashkinDPEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
  • BridevauxP-OGerbaseMWProbst-HenschNMSchindlerCGaspozJ-MRochatTLong-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax20086376877418505800
  • SocietyATStandardization of spirometry, 1994 updateAm Respir Crit Care Med19951511071136
  • MorrisJFSpirometry in the evaluation of pulmonary functionWest J Med1976125110118969495
  • PerkinsSMTuWUnderhillMGZhouXHMurrayMDThe use of propensity scores in pharmacoepidemiologic researchPharmacoepidemiol Drug Saf200099310119025807
  • RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika1983704155
  • ChenZDunsonDBRandom effects selection in linear mixed modelsBiometrics20035976276914969453
  • CerveriICorsicoAGGrossoAThe rapid FEV1 decline in chronic obstructive pulmonary disease is associated with predominant emphysema: a longitudinal studyCOPD201310556123272662
  • WatzHPittaFRochesterCLAn official European Respiratory Society statement on physical activity in COPDEur Respir J2014441521153725359358
  • IncorvaiaCRussoAForesiAEffects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST studyEur J Phys Rehabil Med20145041942624691247
  • LeidyNSextonCJonesPMeasuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diaryThorax201469544344924595666
  • CelliBRPredictors of mortality in COPDRespir Med201010477377920417082
  • HoeseinFAMde HoopBZanenPCT-quantified emphysema in male heavy smokers: association with lung function declineThorax20116678278721474499
  • WashkoGRRate of decline in FEV1: is emphysema the culprit?Am J Respir Crit Care Med20121852322210781
  • CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
  • LeeJSKimSOSeoJBLongitudinal lung volume changes in patients with chronic obstructive pulmonary diseaseLung201319140541223715996